SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    RiesLAG,EisnerMP,KosaryCL, et al., eds. SEER Cancer Statistics Review, 1975–2000, Bethesda, Md: National Cancer Institute; 2003. Available from http://seer.cancer.gov/csr/1975_2000. Accessed on February 20, 2008.
  • 2
    Loeb DM,Arceci RJ. What is the optimal therapy for childhood AML? Oncology (Williston Park). 2002; 16: 10571066; discussion 1066, 1068–1070.
  • 3
    Buckley JD,Lampkin BC,Nesbit ME, et al. Remission induction in children with acute non-lymphocytic leukemia using cytosine arabinoside and doxorubicin or daunorubicin: a report from the Childrens Cancer Study Group. Med Pediatr Oncol. 1989; 17: 382390.
  • 4
    Nesbit MEJr,Buckley JD,Feig SA, et al. Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group. J Clin Oncol. 1994; 12: 127135.
  • 5
    Woods WG,Kobrinsky N,Buckley J, et al. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study. J Clin Oncol. 1993; 11: 14481457.
  • 6
    Wells RJ,Woods WG,Lampkin BC, et al. Impact of high-dose cytarabine and asparaginase intensification on childhood acute myeloid leukemia: a report from the Childrens Cancer Group. J Clin Oncol. 1993; 11: 538545.
  • 7
    Woods WG,Neudorf S,Gold S, et al. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission. Blood. 2001; 97: 5662.
  • 8
    Lange BJ,Dinndorf P,Smith FO, et al. Pilot study of idarubicin-based intensive-timing induction therapy for children with previously untreated acute myeloid leukemia: Children's Cancer Group Study 2941. J Clin Oncol. 2004; 22: 150156.
  • 9
    Leung W,Hudson MM,Strickland DK, et al. Late effects of treatment in survivors of childhood acute myeloid leukemia. J Clin Oncol. 2000; 18: 32733279.
  • 10
    Redaelli A,Stephens JM,Brandt S,Botteman MF,Pashos CL. Short- and long-term effects of acute myeloid leukemia on patient health-related quality of life. Cancer Treat Rev. 2004; 30: 103117.
  • 11
    Michel G,Socie G,Gebhard F, et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation—a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol. 1997; 15: 22382246.
  • 12
    Robison LL,Mertens AC,Boice JD, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol. 2002; 38: 229239.
  • 13
    Efron B,Tibshirani RJ. An Introduction to the Bootstrap. New York, NY: Chapman Hall; 1993.
  • 14
    Clayton D,Hills M. Statistical Models in Epidemiology. New York, NY: Oxford University Press; 1993.
  • 15
    Gooley TA,Leisenring W,Crowley J,Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999; 18: 695706.
  • 16
    Oeffinger KC,Mertens AC,Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006; 355: 15721582.
  • 17
    Liang K,Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986; 73: 1322.
  • 18
    U.S. Census Bureau, Population Division, Current Population Survey (CPS) Reports, Annual Demographic Supplement: Children's Living Arrangements and Characteristics: March 2001. Table HI01: Health Insurance Coverage Status and Type of Coverage by Selected Characteristics, 2001. Available from http://pubdb3.census.gov/macro/032002/health/toc.htm. Accessed on February 20, 2008.
  • 19
    U.S. Census Bureau, Population Division, Education and Social Stratification Branch. Educational Attainment in the United States: March 2001. Detailed tables (PPL-157). Available from http://www.census.gov/population/socdemo/education/ppl-157/tab01.xls. Accessed on February 20, 2008.
  • 20
    U.S. Census Bureau, Population Division, Fertility and Family Statistics Branch. Current Population Survey (CPS) Reports: Children's Living Arrangements and Characteristics: March 2001. Available from http://www.census.gov/population/socdemo/hh-fam/cps2001/tabA1-all.xls. Accessed on February 20, 2008.
  • 21
    U.S. Department of Labor, Bureau of Labor Statistics. Labor Force Statistics from the Current Population Survey, Household Data, Annual Averages, Table 3. Employment Status of the Civilian Noninstitutional Population by Age, Sex, and Race. Washington, DC: U.S. Department of Labor, Bureau of Labor Statistics; 2001.
  • 22
    Hudson MM,Mertens AC,Yasui Y, et al. Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA. 2003; 290: 15831592.
  • 23
    Geenen MM,Cardous-Ubbink MC,Kremer LC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA. 2007; 297: 27052715.
  • 24
    Stevens MC,Mahler H,Parkes S. The health status of adult survivors of cancer in childhood. Eur J Cancer. 1998; 34: 694698.
  • 25
    Neglia JP,Friedman DL,Yasui Y, et al. Second malignant neoplasms in 5-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst. 2001; 93: 618629.
  • 26
    Guibout C,Adjadj E,Rubino C, et al. Malignant breast tumors after radiotherapy for a first cancer during childhood. J Clin Oncol. 2005; 23: 197204.
  • 27
    Bhatia S,Robison LL,Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med. 1996; 334: 745751.
  • 28
    Boice JDJr. Radiation and breast carcinogenesis. Med Pediatr Oncol. 2001; 36: 508513.
  • 29
    Kenney LB,Yasui Y,Inskip PD, et al. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med. 2004; 141: 590597.
  • 30
    Mertens AC,Yasui Y,Neglia JP, et al. Late mortality experience in 5-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol. 2001; 19: 31633172.
  • 31
    Steinherz LJ,Steinherz PG,Tan CT,Heller G,Murphy ML. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA. 1991; 266: 16721677.
  • 32
    Lipshultz SE,Lipsitz SR,Sallan SE, et al. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol. 2005; 23: 26292636.
  • 33
    Mitby PA,Robison LL,Whitton JA, et al. Utilization of special education services and educational attainment among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2003; 97: 11151126.
  • 34
    de Boer AG,Verbeek JH,van Dijk FJ. Adult survivors of childhood cancer and unemployment: a meta-analysis. Cancer. 2006; 107: 111.
  • 35
    Park ER,Li FP,Liu Y,Emmons KM,Ablin A,Robison LL, et al. Health insurance coverage in survivors of childhood cancer: the Childhood Cancer Survivor Study. J Clin Oncol. 2005; 23: 91879197.